Orange Book product · Brand (NDA)
ADENOCARD
ADENOSINE
At a glance
Oct 30, 1989
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 30, 1989
37 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ADENOSINE
Strength
3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 019937
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1995ADENOSCANBrand (NDA)
NDA 020059 · ASTELLAS
- 2018ADENOSINEGeneric (ANDA)
ANDA 205568 · FRESENIUS KABI USA
- 2018ADENOSINEGeneric (ANDA)
ANDA 206778 · GLAND
- 2017ADENOSINEGeneric (ANDA)
ANDA 077897 · FRESENIUS KABI USA
- 2017ADENOSINEGeneric (ANDA)
ANDA 205331 · EUGIA PHARMA
- 2014ADENOSINEGeneric (ANDA)
ANDA 090450 · RISING
- 2014ADENOSINEGeneric (ANDA)
ANDA 202313 · AVET LIFESCIENCES
- 2014ADENOSINEGeneric (ANDA)
ANDA 090212 · MYLAN ASI
- 2014ADENOSINEGeneric (ANDA)
ANDA 203883 · HOSPIRA
- 2014ADENOSINEGeneric (ANDA)
ANDA 078640 · PHARMOBEDIENT
- 2013ADENOSINEGeneric (ANDA)
ANDA 077425 · MEITHEAL
- 2009ADENOSINEGeneric (ANDA)
ANDA 090220 · WOCKHARDT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
